Provided by Tiger Trade Technology Pte. Ltd.

Canadian Imperial Bank of Commerce

114.64
+0.17000.15%
Post-market: 114.58-0.0607-0.05%17:14 EDT
Volume:891.06K
Turnover:102.10M
Market Cap:104.09B
PE:15.49
High:115.79
Open:115.79
Low:113.48
Close:114.47
52wk High:124.86
52wk Low:78.79
Shares:907.94M
Float Shares:891.74M
Volume Ratio:0.83
T/O Rate:0.10%
Dividend:3.02
Dividend Rate:2.63%
EPS(TTM):7.40
EPS(LYR):6.12
ROE:15.58%
ROA:0.89%
PB:2.20
PE(LYR):18.75

Loading ...

Press Release: Castle Biosciences Reports First Quarter 2026 Results

Dow Jones
·
May 07

BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil

GlobeNewswire
·
May 06

Immunocore reports first quarter financial results and provides a business update

GlobeNewswire
·
May 06

Desjardins Remains a Buy on Canadian Bank of Commerce (CM)

TIPRANKS
·
May 06

CIBC price target raised to C$159 from C$153 at Scotiabank

TIPRANKS
·
May 05

Press Release: Hon. Lisa Raitt appointed to Advisory Committee on Canada-U.S. Economic Relations

Dow Jones
·
Apr 22

Canadian Imperial Bank of Commerce Up 13 Days Straight, On Track for Record High Close and Record Winning Streak -- Data Talk

Dow Jones
·
Apr 18

Press Release: CIBC Announces Election of Directors at 2026 Annual and Special Meeting

Dow Jones
·
Apr 17

Canadian Banks See Need for Canada to Act Swiftly to Tackle Challenges

Dow Jones
·
Apr 16

Canadian Imperial Bank of Commerce on Track for Record High Close -- Data Talk

Dow Jones
·
Apr 16

Press Release: CIBC Innovation Banking Serves as Lead Arranger for Vena Solutions' Expanded Credit Facility and Syndicate to Support Acquisition of Acterys

Dow Jones
·
Apr 15

Want Bank Dividends? Head Up North. -- Barrons.com

Dow Jones
·
Apr 14

Assessing BridgeBio Pharma (BBIO) Valuation After Key ATTR-CM And LGMD2I/R9 Milestones

Simply Wall St.
·
Apr 13

Analysts Offer Insights on Financial Companies: AMP (OtherAMLTF), Banco De Chile (BCH) and Canadian Bank of Commerce (CM)

TIPRANKS
·
Apr 04

BridgeBio presents long-term efficacy, safety data from ATTRibute-CM trial

TIPRANKS
·
Mar 31

Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54

GlobeNewswire
·
Mar 31

Powerlong CM Posts Flat 2025 Revenue but Higher Profit as Retail Portfolio Expands

TIPRANKS
·
Mar 31

CM Energy's Profit Plunges 83% in 2025; Shares Drop 3%

MT Newswires Live
·
Mar 30

STAR CM Narrows Annual Loss as Gross Profit More Than Doubles in 2025

TIPRANKS
·
Mar 28

RBC Capital Keeps Their Buy Rating on Canadian Bank of Commerce (CM)

TIPRANKS
·
Mar 27